CTOs on the Move

Huupe

www.huupe.com

 
Founded in 2016, Huupe is the first-ever smart basketball hoop. It brings competition and training to basketball enthusiasts and players, including NBA athletes as well as stars from the league who have invested in the company. Huupe`s groundbreaking innovation enables ages eight and up to compete on the court or virtually, learn and improve their skills, track their progress, and more. The appointment of Paul as CTO follows the company`s 400% growth month over month in the past six months this year, with 50% growth in October 2022 alone, and viral popularity on social media.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Laxai

Laxai is a South Plainfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Home Care Medical

Serving Southeastern Wisconsin since 1974, Home Care Medical, Inc. provides home infusion, enteral nutrition and hospice care; rehab technology; respiratory care; home medical equipment and supplies; and bracing and compression garments. In addition to the Corporate Headquarters located at 5665 South Westridge Drive in New Berlin, Wisconsin, Home Care Medical, Inc. has three retail store locations at 4818 South 76th Street in Milwaukee, Wisconsin; 2922 South Business Drive in Sheboygan, Wisconsin; and 1709 South 18th Avenue in West Bend, Wisconsin. Home Care Medical, Inc. is the WAMES (Wisconsin Association of Medical Equipment Services) HME Provider of the Year award recipient in 2013 and 2012. Accredited by the Joint Commission and an active member of WAMES, the MedGroup and AAHomecare, Home Care Medical’s mission is to enhance the lives of those we serve.

Waldorf Technik

Waldorf Technik is a Saint Charles, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Acucela

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.

EMD Millipore

"At EMD Millipore, one of the top three investors in R&D in the Life Science Tools industry, we develop cutting-edge technologies and services for bioscience research and biopharmaceutical manufacturing. Innovation drives everything we do. And it’s reinforced by our collaborative culture, pioneering spirit and unwavering focus on the world’s most challenging human health issues. EMD Millipore, known outside North America as Merck Millipore, is part of the Merck Group, a global company with 40,000 employees in more than 60 countries. EMD Millipore is a division of Merck KGaA, Darmstadt, Germany."